RBCC Seeks Out New Breakthroughs at Biotech Showcase 2013

  RBCC Seeks Out New Breakthroughs at Biotech Showcase 2013

Biotech Showcase 2013

Business Wire

NOKOMIS, Fla. -- January 8, 2013

Rainbow Coral Corp. (OTCBB: RBCC) leadership is in San Francisco this week to
scout exciting new biotech partnership opportunities at Biotech Showcase ™
2013.

Biotech Showcase is focused on providing private and public biotechnology
companies the opportunity to meet with, and present ideas to, investors and
executives from around the world. The major industry event draws the attention
of the largest players and investors in biotechnology with investors.

This year, the showcase is expected to attract upwards of 1,500 attendees.

“Biotech Showcase 2013 is a crucial opportunity for our company to network
with brilliant young entrepreneurs and emerging businesses with the potential
to grow our base of assets and increase our value to shareholders,” said RBCC
CEO Patrick Brown. “We’ll be specifically targeting new projects that exhibit
short paths to marketability in order to grow our business as quickly as
possible.”

The Company’s biotech subsidiary, Rainbow Biosciences, is close to finalizing
a joint venture with Amarantus to develop and market new therapies and
treatments for both neurological diseases including Parkinson’s and physical
traumas such as brain injury.

The company hopes to bolster its portfolio of projects for commercialization
at this week’s showcase.

Rainbow BioSciences is dedicated to developing new medical and research
technology innovations to compete alongside companies such as Amgen Inc.
(NASDAQ:AMGN),Cell Therapeutics, Inc. (NASDAQ: CTIC) and Abbott Laboratories
(NYSE:ABT).

For more information on Rainbow BioSciences, please
visitwww.rainbowbiosciences.com/investors.

Follow us on Twitter atwww.twitter.com/RBCCinfo.

About Rainbow BioSciences

Rainbow BioSciences is a division ofRainbow Coral Corp.(OTCBB:RBCC). The
company continually seeks out new partnerships with biotechnology developers
to deliver profitable new medical technologies and innovations. For more
information on our growth-oriented business initiatives, please visit our
website atwww.rainbowbiosciences.com. For investment information and
performance data on the company, please
visitwww.RainbowBioSciences.com/investors.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including statements
that include the words "believes," "expects," "anticipate" or similar
expressions. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the company to differ materially from those expressed or
implied by such forward-looking statements. In addition, description of
anyone's past success, either financial or strategic, is no guarantee of
future success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information included
herein for events occurring after the date hereof.

Contact:

Rainbow Coral Corp.
Patrick Brown, 813-367-9511
President and CEO
info@rainbowcoral.com
 
Press spacebar to pause and continue. Press esc to stop.